
Single-Cell Transcriptional Analysis Reveals the Mechanism of AZD6738 in HCC Immunotherapy via EZH2 Targeting
Introduction Hepatocellular carcinoma (HCC) stands as the fifth most prevalent malignancy globally and ranks as the second principal contributor to cancer-related mortality.1,2 HCC is one of several subtypes of primary liver cancer (PLC), which also …